지나인제약 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 지나인인베스트먼트, was filed 27 Jul 2022.
지나인제약: what insiders have been doing
지나인제약, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Nothing new has been filed by managers of 지나인제약 in twelve months, the latest record being from 16 March 2023.
Other companies in the same sector with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Financial data
· cache
- ●Executives0DART
- 257,953 sharesKRXDART:20220812000306
- 257,953 sharesKRXDART:20220727000199
- 257,953 sharesShareKRXDART:20220727000206Canonical exit: 18 Oct 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 27 declarations
About 지나인제약
지나인제약 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.
